Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review

Abstract Background Nicotine use and nicotine use disorder (NUD) are the leading causes of preventable death in the United States. Persons with mental disorders  (e.g., bipolar disorder) are differentially susceptible to nicotine use. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are indicate...

Full description

Saved in:
Bibliographic Details
Main Authors: Serene Lee, Maggie Li, Gia Han Le, Kayla M. Teopiz, Maj Vinberg, Roger Ho, Hezekiah C. T. Au, Sabrina Wong, Kyle Valentino, Angela T. H. Kwan, Joshua D. Rosenblat, Roger S. McIntyre
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Annals of General Psychiatry
Subjects:
GLP-1
Nicotine use disorder
Exenatide
Liraglutide
Nicotine
Semaglutide
Online Access:https://doi.org/10.1186/s12991-024-00527-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12991-024-00527-9

Similar Items